Trial | NCT02720354  Report issue

Official Title

A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    dmdpa ...

  • Study Participants

    12
[11C]-dimethyl-diphenyl ammonium ([11C]-DMDPA) - A Phase I, Open-label, Safety and Tolerability, Radiation Dosimetry, Biodistribution, First-in-Human Study of a Novel 11C-labeled Tracer for Positron Emission Tomography Myocardial Perfusion Imaging
Study Started
May 31
2016
Primary Completion
Feb 28
2017
Study Completion
May 31
2017
Last Update
Oct 20
2017

Other [11C]-DMDPA

A single Intravenous bolus injection Experimental

A single Intravenous bolus injection of 11C[DMDPA]

Criteria 

Inclusion Criteria:

body mass index (BMI) between 18.0 and 30.0 kg/m2
good health
written informed consent

Exclusion Criteria:

smokers
subject receiving medication
a blood transfusion in the 4 weeks prior to screening
positive alcohol blood test
Subjects who suffer from claustrophobia
Subjects who have had a clinically significant illness
Subjects exposed to radiation within 12 months prior to screening
No Results Posted